Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Treating Fields (TTFields) Concomitant With Stereotactic Radiosurgery Based on FET-PET vs TTFields Alone for the Treatment of Recurrent, Glioblastoma (Tarrget 2.0)

NCT07668869 is registered in ClinicalTrials.gov with Prof. Franciszek Lukaszczyk Memorial Oncology Center as lead sponsor.

NCT NCT07668869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Treating Fields (TTFields) Concomitant With Stereotactic Radiosurgery Based on FET-PET vs TTFields Alone for the Treatment of Recurrent, Glioblastoma (Tarrget 2.0)
Lead sponsor
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 30, 2025
Completion date
June 30, 2032
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioblastoma idh (isocitrate dehydrogenase) wildtype, glioblastoma multiforme, adult